相似文献
1
A proteomic primer for the clinician.
Proc Am Thorac Soc. 2007 Jan;4(1):9-17. doi: 10.1513/pats.200608-156JG.
2
Proteomics for hepatocellular carcinoma marker discovery.
Gastroenterology. 2004 Nov;127(5 Suppl 1):S120-5. doi: 10.1053/j.gastro.2004.09.025.
3
Biomarker discovery: proteome fractionation and separation in biological samples.
Physiol Genomics. 2008 Mar 14;33(1):12-7. doi: 10.1152/physiolgenomics.00282.2007. Epub 2007 Dec 27.
4
Limitations of current proteomics technologies.
J Chromatogr A. 2005 Jun 3;1077(1):1-18. doi: 10.1016/j.chroma.2005.04.059.
5
Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
Jpn J Clin Oncol. 2013 Feb;43(2):103-9. doi: 10.1093/jjco/hys200. Epub 2012 Dec 16.
6
Proteomics.
Curr Opin Nephrol Hypertens. 2003 Jul;12(4):423-30. doi: 10.1097/00041552-200307000-00011.
7
Teaching molecular genetics: Chapter 3--Proteomics in nephrology.
Pediatr Nephrol. 2006 May;21(5):611-8. doi: 10.1007/s00467-006-0064-z. Epub 2006 Mar 30.
8
Advances in top-down proteomics for disease biomarker discovery.
J Proteomics. 2011 Jun 10;74(7):920-34. doi: 10.1016/j.jprot.2011.03.030. Epub 2011 Apr 6.
9
Proteomics in pediatric research and practice.
Adv Pediatr. 2007;54:9-28. doi: 10.1016/j.yapd.2007.03.003.
10
Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Mass Spectrom Rev. 2010 Nov-Dec;29(6):945-61. doi: 10.1002/mas.20296.
引用本文的文献
1
Different Stationary Phase Selectivities and Morphologies for Intact Protein Separations.
Chromatographia. 2017;80(5):665-687. doi: 10.1007/s10337-016-3168-z. Epub 2016 Sep 23.
2
Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury.
Biomedicine (Taipei). 2014;4(4):23. doi: 10.7603/s40681-014-0023-0. Epub 2014 Nov 20.
3
Proteomics and mass spectrometry: what have we learned about the heart?
Curr Cardiol Rev. 2010 May;6(2):124-33. doi: 10.2174/157340310791162631.
4
Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis.
Int J Colorectal Dis. 2009 Nov;24(11):1271-9. doi: 10.1007/s00384-009-0759-2. Epub 2009 Jul 14.
本文引用的文献
1
Investigation of an albumin-enriched fraction of human serum and its albuminome.
Proteomics Clin Appl. 2007 Jan 1;1(1):73-88. doi: 10.1002/prca.200600276.
2
Subfractionation of heart tissue: the "in sequence" myofilament protein extraction of myocardial tissue.
Methods Mol Biol. 2007;357:87-90. doi: 10.1385/1-59745-214-9:87.
3
A solubility optimization protocol for two-dimensional gel electrophoresis of cardiac tissue.
Methods Mol Biol. 2007;357:59-65. doi: 10.1385/1-59745-214-9:59.
4
Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis.
Mol Cell Proteomics. 2006 Dec;5(12):2392-411. doi: 10.1074/mcp.T500036-MCP200. Epub 2006 Sep 25.
5
When does a fingerprint constitute a diagnostic?
Lancet. 2006 Sep 16;368(9540):971-3. doi: 10.1016/S0140-6736(06)69379-3.
6
Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways.
Circ Res. 2006 Sep 29;99(7):706-14. doi: 10.1161/01.RES.0000243995.74395.f8. Epub 2006 Aug 31.
7
Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage.
Proteomics. 2006 Jul;6(13):3949-57. doi: 10.1002/pmic.200500693.
8
Possible dysregulation of chaperon and metabolic proteins in cystic fibrosis bronchial tissue.
Proteomics. 2006 Jun;6(11):3381-8. doi: 10.1002/pmic.200500487.
9
Proteomics and heart disease: identifying biomarkers of clinical utility.
Expert Rev Proteomics. 2006 Apr;3(2):237-49. doi: 10.1586/14789450.3.2.237.
10
SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas.
Pathol Res Pract. 2005;201(12):763-70. doi: 10.1016/j.prp.2005.08.011. Epub 2005 Oct 24.
Zotero 插件